Skip to content

Life Study: Lifestyle Intervention in Fibroid Elimination

Effects of Implementing a Post-surgical Dietary and Lifestyle Protocol on Uterine Fibroid Recurrence

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05416424
Enrollment
100
Registered
2022-06-13
Start date
2022-05-23
Completion date
2027-01-31
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Fibroid

Brief summary

The study will evaluate a lifestyle, nutrition, and exercise program to assess whether this program is acceptable and feasible for patients..Researchers will examine if the LIFE program can modify fibroid recurrence.

Detailed description

This prospective cohort pilot study will enroll asymptomatic, post-surgical patients who underwent a laparoscopic, open, robotic myomectomy, or other procedure ie Sonata, Accessa for fibroid removal. Patients will be offered enrollment into a lifestyle, nutrition, supplement, and exercise program to assess whether this program is acceptable and feasible for patients. Surveys will be collected at 3-6 month intervals.

Interventions

OTHERLIFE program

During the nutritionist visits, subjects will be asked to discuss and evaluate their current diet and will be given recommended dietary changes. The recommended dietary changes include focusing on eating nutrient dense foods, staying consistent with the timing of meals, limiting added sugars, aiming to have balanced meals and snacks, being a mindful eater, and aiming to drink approximately 2 liters of water a day. Additionally, they will review the nutrition survey with the registered dietician. During the office visits with a doctor, subjects will be given exercise counseling. They will be asked to do 150 minutes per week of moderate intensity aerobic activity

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants ages 18-50, who are seeking care at the Center for Fibroid Care at NYU * Participants who have had a procedure or surgery performed to removed fibroids within the last 3 months and are now considered fibroid free. * Be English speaking and be able to read/write in English * Visit with PCP within the last 3 months with labs

Exclusion criteria

* Currently Pregnant * Use of any medication, hormonal or GNRH agonists, that would affect fibroid growth * Postmenopausal women * Non-English speaking * Fibroid procedure or surgery outside of the 3-month window * Women who are physically incapable of following a physical activity regimen * Women with multiple dietary restrictions that would impact their ability to follow recommended dietary plan. (ie. GI disorders)

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of LIFE program as measured by Self report survey12 month visit.Patient satisfaction survey will assess if patients found the program acceptable on a 5 point Likert scale ( not at all acceptable, fair, moderate, good excellent).
Change in improvement in quality of life as measured by Quality of Life Scale (QOLS)Baseline, 6 month, 12 monthThe Quality of Life Scale (QOLS) was originally a 15-item instrument that measured five conceptual domains of quality of life: material and physical well-being, relationships with other people, social, community and civic activities, personal development and fulfillment, and recreation. Using a 7-point response scale, scores are summed so that a higher score indicates higher quality of life. The QOLS is scored by adding up the score on each item to yield a total score for the instrument. Scores can range from 16 to 112.
Change in fibroid recurrence as measured by standard of care ultrasoundsBaseline, 6 month, 12 monthAdherence to a lifestyle program changes rate of fibroid recurrence as assessed by standard of care pelvic ultrasound results.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026